Evidence map›Paper›PMID 30271632›Full record

ArticleInternational journal of Alzheimer's disease2018

Impaired Cerebral Vasomotor Reactivity in Alzheimer's Disease.

Fernando Gongora-Rivera, Adolfo Cordero-Perez, Alejandro Gonzalez-Aquines, Antonio Anaya-Escamilla, Eduardo Villarreal-Garza, Meztli Espinosa-Ortega, Mario C Salinas-Carmona, Xochilt Ortiz-Jimenez

Open access · hybridAbstract read
In one paragraph

Article in International journal of Alzheimer's disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Association BetweenInfection and drug resistance · 2025
    Review
  3. Review
  4. Cerebral vasomotor reactivity across the continuum of subjective cognitive impairment, amnestic mild cognitive impairment and probable Alzheimer's dementia: A transcranial Doppler and PET/MRI study.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Fernando Gongora-RiveraDepartamento de Neurología, "Dr. José Eleuterio González" Hospital Universitario y Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico.ORCID 0000-0003-1224-3942
Adolfo Cordero-PerezDepartamento de Neurología, "Dr. José Eleuterio González" Hospital Universitario y Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Alejandro Gonzalez-AquinesDepartamento de Neurología, "Dr. José Eleuterio González" Hospital Universitario y Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Antonio Anaya-EscamillaDepartamento de Neurología, "Dr. José Eleuterio González" Hospital Universitario y Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico.ORCID 0000-0002-4231-9701
Eduardo Villarreal-GarzaDepartamento de Neurología, "Dr. José Eleuterio González" Hospital Universitario y Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Meztli Espinosa-OrtegaDepartamento de Neurología, "Dr. José Eleuterio González" Hospital Universitario y Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Mario C Salinas-CarmonaUnidad de Neuromodulación y Plasticidad Cerebral, Centro de Investigación y Desarrollo en Ciencias de la Salud, Universidad Autónoma de Nuevo León (UANL), Monterrey, NL, Mexico.
Xochilt Ortiz-JimenezDepartamento de Neurología, "Dr. José Eleuterio González" Hospital Universitario y Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Mexico.
Universidad Autónoma de Nuevo León · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent studies have shown that cerebral vascularity may be impaired in Alzheimer's disease. Cerebral vasomotor reactivity could be an important biomarker for this pathology.

aimsThe aim of this study was to investigate the alterations in cerebral vascular motor reactivity in Alzheimer's disease subjects and to associate these changes with their cognitive scores.

methodsWe recruited subjects with a diagnosis of Alzheimer's disease and healthy controls. Demographic, clinical, imaging, and cognitive test were obtained. Then all participants performed a cerebral vascular motor reactivity test with 7% CO2 and cerebral blood flow velocities (CBFV) were recorded with transcranial doppler ultrasound before and after the test.

resultsWe recruited 45 subjects, 26 (21 female) Alzheimer's disease participants and 19 (15 female) healthy controls. There were no differences in baseline cerebral blood flow velocities between the groups. After the cerebral vasomotor reactivity test, absolute mean difference in mean CBFV (ΔCBFV-m) was 8.70±4.14 versus 4.81±6.96 (p<0.01), respectively. Calculated percentage of change (%CVMR) was lower in the AD group 7.45±18.25 versus 23.29±17.48, and there was a positive but weak correlation with mini-mental scores (

conclusionsIn this study, Alzheimer's disease subjects showed significant changes in all absolute cerebral blood flow velocities after the cerebral vasomotor reactivity test with CO2, but only diastolic phase responses were statistically significant. There was a positive but weak correlation between cerebral vasomotor reactivity and cognitive scores. Further studies are needed to investigate these effects in larger Latin-American samples.

Identifiers

PMID30271632
PMCPMC6151226
OpenAlexW2890477042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.